ML20198M767
| ML20198M767 | |
| Person / Time | |
|---|---|
| Site: | Washington State University |
| Issue date: | 01/09/1998 |
| From: | Mendonca M NRC (Affiliation Not Assigned) |
| To: | Tripard G WASHINGTON STATE UNIV., PULLMAN, WA |
| References | |
| TAC-M79607, NUDOCS 9801200116 | |
| Download: ML20198M767 (5) | |
Text
- _ - _ _ -.
January 9, 1998 Dr. Gerald E. Tripard, Director Nuclear Radiation Center.
Washington State University Pullman, Washington 99164 SUPJECT: REQUEST FOR ADDITIONAL INFORMATION (TAC NO. 79007)
Dear Dr. Tripard:
We are continuing our review of your September 25,1995,' January 8,1996, February 23, 1996, and May 15,1997, rsquests for amendment of the Washington State University Research Reactor Technical Specifications. During our review, questions have arisen for which we require additionalinformation and clarification. Please proviJe responses to the enclosed request for additionalinformation within 60 days of the date of this letter. In accordance with 10 CFR 50.?0(b), your response must be executed in a signed original under obth or affirmation. This request affects nine or fewer respondents and therefore,is not subject to Office of Management and Budget review under P. L. 290 511. Following receipt of the additionalinformation, we will continuo our evaluatinn of your application.
if you have any questions regarding this nalew, please contact me at (301) 4151128.
Sincerely, original signed by:
Marvin M. Mendonca, Senior Project Manager Non-Power Reactors and Decommissioning Project Directorate Division of Reactor Program Management Offics "mlear Reactor Regulation Dnckst No. 50 27
Enclosure:
Request for AdditionalInformation gg g
- cc w/ enclosure:
See next page DISTRIBUT10B E-MAIL
. IMER. COPY 1
TBurdick lTDragoun Piscoc
- LOsche(File 50407] JRoe PDoyle TM!chaels PUBUC' SWeiss
, [o \\
' CBassett:
. WEresian.
EHylton PDND r/f AAdams SHolmes.
MMendonca OGG PDND:PM U P
d P-MMendonca -
n SWeiss -
I
)
1/ ftg8 1y'/98f
/98
- OFFICIAL RECORD COPY-I
' DOCUMENT NAME: A:\\RAI79607 '
I 9901200116 980109 PDR ADOCK 0S000027 P
~
~
s u
4 p...,k d
UNITso STATES g-s
}
NUCLEAR REGULATORY COMMISSION WASHINGTON. D.C. 30006 4001
%,,, g *!.
January 9, 1998 Dr. Gerstd E. Tripard, Director Nuclear Radiation Center Washington State University Pullman, Washington 99164
SUBJECT:
REQUEST FOR ADDITIONAL INFORMATION (TAC NO. 79607)
Dear Dr. Tripard:
We are continuing our review of your September 25,1995, January 8,1996, February 23, 1996, and May 15,1997, requests for amendment of the Washington State University Research Reactor Technical Specifications. During our review, questions have arisen for which we require additionalinformation and clarification. Please provide responses to the enclosed request for additionalinformation within 60 days of the date of this letter. In accordance with 10 CFR 50.30(b), your respo.ise must be executed in a signed original under oath or affirmation. This request affects nine or fewer respondents and therefore,is not subject to Office of Management and Budget review under P. L. 296 511. Following receipt of the additionalinformation, we will continue our evaluation of your application.
If you have any questions regarding this review, please contact me nt (301) 4151128.
Sincerely, h
uM.
Mcryin M. Mendonca, Senior Project Manager Non Power Reactors and Decommissioning Project Directorate Division of Reactor Program Management Office of Nuclear Reactor Regulation Docket No. 50-27
Enclosure:
Request for AdditionalInformation cc w/ enclosure:
See next page
Washington State University Docket No. 60 27 cc:
State Aanning Division
. Office of Financial Management Room 105, House Of fice Building Olymple, Washington 98504 d
b 3
1
_.f s
- - - - ~
-~
~
p ENCLOSURE f
REQUEST FOR ADDITIONAL INFORMATION WASHINGTON STATE UNIVERSITY RESEARCH REACTOR DOCKET NO. 50 27 1.
The review of the sucmittals is in part to ensure medical use or human irradiation by the neutron beam is not permitted. The technicalinformation was not reviewed for human therapy. Additionalinformation and license authority and controls would be required for human therapy. Therefore, the "Appt'cability" section page 2 of the May 15,1997, Tech Spec should be amended to explicitly state the neutron beam generated will not be used for the irradiation of human subjects or any parts of live human subjects.
t 2.
Provide drawings or diagrams appropriate to demonstrate the configuration of the BNC i
facility. Indicate the locstions of the major sr.fety features including the control panel, access gate, Gameras, monitors, and reactor log power, linear power levels and reactor position indications. Describe how the reactor is scrammed from the control panel.
Describe the access gate.
3.
Def!nition 4 on page 1 of the Tech Specs with the May 15,1997, submittal, indicates a 119% that was identified as a typographical error in the January 8,1996, submittal. Provide corrections or analysis as appropriate for the entire proposed Tech Specs.
4.
Definition 1, page 1 of the May 15,1997, Tech Specs, provides that the experimental I
bench, positioning equipment, and other equipment used for the beam targeta are not considered part of the BNC facility (in the case of medical treatment those may be provided by the medical use licensee and in that case would not be part of tho BNC facility). Describe the reactor or facility controls that pertain to these components.
- 5.
Describe the acceracy tenuirements on the position of the reactor bridge. Describe how accurate is the alternative method identified in Specification 4 page 19b (Specification 4, page 3, May 15,1997) in verifying the position of the bridge position? Provide ecceptance criteria that will be followed for the alternate reactor bridge position indicatic, means allowed by Specification 4 of page 3 of the Mav 15, 1997, submittal.
6.
Specification 10g of page 6.n the May 15 1997, submittal, indicates that the bridge
.can be moved manually from within the f acility. This may be confused with the BNC f acility. Provide clarification.
l E
.~
l j
t 2-
' i 7.
Term " medical"In Specification 10n may be confus-with treatment of human patients. Remove the term from here and any where else it may have been used in the Tech Specs 8.-
Provide a description of the controls to ensure that the monitor's sudible alarm (as described in the basis)is disabled on!y after the BNC facility is secured so that access is controlled if the beam is active, and that the alarm is reinstated prior to activating the beam.
9.
Clarify the location of and controls for the instructions in Specification 14.(b)(li) to notify the operator of abnormalities.
t 4
.5
~
-.